Table 4 Associations between participation in follow-up screening and treatment with glucose lowering agents
Crude OR (95% CI) | Adjusted* OR (95% CI) | |
|---|---|---|
General practitioner | ||
Control 1: Within 3 months after birth | 2.2 (1.5-3.5) | 2.3 (1.5-3.5) |
Control 2: 3 months to 2 years | 7.4 (5.1-10.6) | 7.1 (4.9-10.3) |
Control 3: 2 years to 4 years | 8.1 (5.9-11.2) | 8.1 (5.9-11.3) |
Control 4: 4 years to 6 years | 8.8 (6.5-12.1) | 8.9 (6.5-12.2) |
Biochemical unit** | ||
Control 1: Within 6 months after birth | 3.1 (1.7-5.5) | 2.9 (1.6-5.3) |
Control 2: 6 months to 2.4 years | 3.8 (2.0-7.3) | 3.5 (1.8-6.9) |
Control 3: 2.4 years to 4.5 years | 3.3 (1.2-8.9) | 2.5 (0.8-7.4) |
Control 4: 4.5 years to 8.2 years | 7.9 (1.4-43.8) | 8.7 (1.5-49.4) |